Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Lung Neoplasms 4Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Endometrial Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Rectal Neoplasms 1Prostatic Neoplasms 1Pneumonia 1Pleuropulmonary blastoma 1Pancreatitis, Chronic 1Neurocognitive Disorders 1Neuroblastoma 1Neoplasm Metastasis 1Meningioma 1Lung Diseases, Interstitial 1Immunoglobulin G4-Related Disease 1Ganglioneuroblastoma 1Carcinoma, Renal Cell 1Carcinoma, Adenoid Cystic 1Carcinoma 1Breast Carcinoma In Situ 1Autoimmune Pancreatitis 1Anus Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Specimen Handling 16Magnetic Resonance Spectroscopy 15Gemcitabine 14pembrolizumab 11Cisplatin 11Mitomycin 7Radiation 6Fluorouracil 6Cystoscopy 6enfortumab vedotin 5avelumab 5Biopsy 5dehydroftorafur 4Transurethral Resection of Bladder 4Radiotherapy 4Platinum 4Nivolumab 4Mitozytrex 4Carboplatin 41,2-diaminocyclohexaneplatinum II citrate 4erdafitinib 3durvalumab 3cabozantinib 3Immunoglobulin G 3Disulfides 3sapanisertib 2olaparib 2eribulin 2atezolizumab 2Surveys and Questionnaires 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Observation × 30 days × Clear all
NCT04216290 2026-05-22

A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

National Cancer Institute (NCI)

Phase 2 Active not recruiting
11 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡